S.no | Product | Efficacy | Year | Country | Status | Reference |
---|---|---|---|---|---|---|
1 | Aflasafe SN01 | 100% | 2021 | Senegal and Gambia | Registered | Senghor et al. 2021 |
2 | Aflasafe GH01, GH02 | 99% | 2020 | Ghana | Registered | Agbetiameh et al. 2020 |
3 | Aflasafe Nigeria |  < 80% | 2016 | Nigeria | Registered | Bandyopadhyay et al. 2016 |
4 | Aflasafe KE01 |  < 90% | 2016 | Kenya | Registered | Bandyopadhyay et al. 2016 |
5 | Aflaguard | 97.38 to 99.82% | 2004 | US | Registered | Dorner and Lamb 2006 |
6 | AF36 | 20–45% | 2003 | US | Registered | |
7 | AF-X1 |  > 90% | 2018 | Italy | Registered | Mauro et al. 2018 |
8 | CT3 | 86% | 2005 | Southern U.S | Registered | Abbas et al. 2006 |
9 | K49 | 60% | 2005 | Southern U. S | Registered | Abbas et al. 2006 |
10 | Aflasafe BF01 |  > 96% | 2016 | Burkina Faso | Not registered | Konlambigue et al. 2020 |
11 | AR27 | – | 2015 | Northern Argentina | Not registered | Zanon et al. 2016 |
12 | AR100G | – | 2015 | Northern Argentina | Not registered | Zanon et al. 2016 |
13 | AFCHG2 | – | 2015 | Northern Argentina | Not registered | Zanon et al. 2016 |
14 | BN30 | – | 2008 | Africa | Not registered | Cardwell and Henry 2008 |
15 | AF051 | – | 2008 | China | Not registered | Yin et al. 2008 |
16 | FS10 | – | 2013 | China | Not registered | Xu et al. 2013 |
17 | BN30 | – | 2008 | Africa | Not registered | Yin et al. 2008 |
18 | Aflasafe TZ01 | – | 2017 | Tanzania | Not registered | Mahuku 2017 |
19 | Aflasafe TZ02 | – | 2017 | Tanzania | Not registered | Mahuku 2017 |
20 | Aflasafe ZM01 & ZM02 | – | 2017 | Zambia | Not registered | Mahuku 2017 |
21 | Aflasafe MW01 & MWMZ01 | – | 2017 | Malawi | Not registered | Mahuku 2017 |
22 | Aflasafe MZ01 & MWMZ01 | – | 2017 | Mozambique | Not registered | Mahuku 2017 |
23 | AflaPak | – | 2020 | Pakistan | Not registered | Ajmal 2022 |